Ads
related to: fibromyalgia and sleep disorders treatment
Search results
Results From The WOW.Com Content Network
Fibromyalgia is estimated to affect 2 to 4% of the population. [13] Women are affected more than men. [4] [13] Rates appear similar across areas of the world and among varied cultures. [4] Symptoms of fibromyalgia are persistent in nearly all patients. [14] The treatment of fibromyalgia is symptomatic [15] and multidisciplinary. [16]
Polysomnography shows reduced sleep efficiency and may include alpha intrusion into sleep EEG. ME/CFS can be comorbid with sleep disorders such as narcolepsy, sleep apnea, PLMD, etc. [20] As with chronic fatigue syndrome, fibromyalgia may be associated with anomalous alpha wave activity (typically associated with arousal states) during NREM ...
Furthermore, it may be necessary to evaluate psychiatric diseases, such as depression or substance use disorder, as well as neurological disorders, such as narcolepsy, multiple sclerosis, and craniocervical instability. [12] [33]: 57 Finally, sleep disorders, coeliac disease, and side effects of medications may also explain symptoms. [12]
It could help people manage fibromyalgia. Some evidence shows that CoQ10 supps may help with fibromyalgia, which is a muscle pain disorder that’s more common in women, Dr. Mulvihill says.
Functional somatic syndrome (FSS) is any of a group of chronic diagnoses with no identifiable organic cause.It encompasses disorders such as fibromyalgia, chronic widespread pain, temporomandibular disorder, irritable bowel syndrome, [1] lower back pain, tension headache, atypical face pain, non-cardiac chest pain, insomnia, palpitation, dyspepsia and dizziness. [2]
The most common sleep-related symptom of bipolar disorder is insomnia, in addition to hypersomnia, nightmares, poor sleep quality, OSA, extreme daytime sleepiness, etc. [27] Moreover, animal models have shown that sleep debt can induce episodes of bipolar mania in laboratory mice, but these models are still limited in their potential to explain ...
Idiopathic hypersomnia (IH) is a neurological disorder which is characterized primarily by excessive sleep and excessive daytime sleepiness (EDS). [1] Idiopathic hypersomnia was first described by Bedrich Roth in 1976, and it can be divided into two forms: polysymptomatic and monosymptomatic.
The clinical practice of behavioral sleep medicine applies behavioral and psychological treatment strategies to sleep disorders. [3] [12] BSM specialists provide clinical services including assessment and treatment of sleep disorders and co-occurring psychological symptoms and disorders, often in conjunction with pharmacotherapy and medical devices that may be prescribed by medical professionals.